• Je něco špatně v tomto záznamu ?

Goeckerman Regimen Reduces Alarmin Levels and PASI Score in Paediatric Patients with Psoriasis

D. Holmannová, B. Císařová, P. Borský, Z. Fiala, C. Andrýs, K. Hamaková, T. Švadláková, J. Krejsek, V. Palička, L. Kotingová, L. Borská

. 2021 ; 64 (4) : 204-212. [pub] -

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22009415

Grantová podpora
Q40-09 Univerzita Karlova v Praze
Q40-10 Univerzita Karlova v Praze
Q40-11 Univerzita Karlova v Praze
SVV-260543/2020 Univerzita Karlova v Praze

BACKGROUND: Psoriasis is a chronic systemic inflammatory disease with (extra-)cutaneous manifestations. Inflammation is associated with cellular stress and tissue damage which lead to the release of alarmins (signals of danger). Goeckerman regimen (GR) is a highly efficacious treatment consisting of the application of pharmaceutical crude tar and UVB light exposure. The reduction of inflammatory processes in the skin is accompanied by changes in the levels of inflammatory markers - alarmins (HMBG-1, S100A7, S1000A8, S100A9, S100A12, IL-17, IL-22, and IL-33). METHODS: The alarmin levels in sera of 19 paediatric patients with psoriasis were determined before and after GR using commercial ELISA kits. The Psoriasis area severity index (PASI) was used to determine the disease severity. RESULTS: GR reduced both PASI and the levels of all measured alarmins. The levels of S100A7, S100A9, IL-22, IL-33, and HMGB-1 were significantly decreased. Positive correlations between IL-22 and PASI, between S100A9 and IL-17, S100A9 and IL-22, and a negative correlation between S100A8 and IL-33 were found. CONCLUSIONS: Goeckerman regimen is a very effective, safe and low-cost therapy. We confirmed, it modulates the immune system reactivity, ameliorates the severity of the disease and reduces the levels of alarmins reflecting the presence and intensity of inflammation.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22009415
003      
CZ-PrNML
005      
20220607092735.0
007      
ta
008      
220419s2021 xr f 000 0|eng||
009      
AR
024    7_
$a 10.14712/18059694.2022.3 $2 doi
035    __
$a (PubMed)35285442
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Holmannová, Dráža, $u Institute of Preventive Medicine, Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic $d 1978- $7 mzk2007411153
245    10
$a Goeckerman Regimen Reduces Alarmin Levels and PASI Score in Paediatric Patients with Psoriasis / $c D. Holmannová, B. Císařová, P. Borský, Z. Fiala, C. Andrýs, K. Hamaková, T. Švadláková, J. Krejsek, V. Palička, L. Kotingová, L. Borská
520    9_
$a BACKGROUND: Psoriasis is a chronic systemic inflammatory disease with (extra-)cutaneous manifestations. Inflammation is associated with cellular stress and tissue damage which lead to the release of alarmins (signals of danger). Goeckerman regimen (GR) is a highly efficacious treatment consisting of the application of pharmaceutical crude tar and UVB light exposure. The reduction of inflammatory processes in the skin is accompanied by changes in the levels of inflammatory markers - alarmins (HMBG-1, S100A7, S1000A8, S100A9, S100A12, IL-17, IL-22, and IL-33). METHODS: The alarmin levels in sera of 19 paediatric patients with psoriasis were determined before and after GR using commercial ELISA kits. The Psoriasis area severity index (PASI) was used to determine the disease severity. RESULTS: GR reduced both PASI and the levels of all measured alarmins. The levels of S100A7, S100A9, IL-22, IL-33, and HMGB-1 were significantly decreased. Positive correlations between IL-22 and PASI, between S100A9 and IL-17, S100A9 and IL-22, and a negative correlation between S100A8 and IL-33 were found. CONCLUSIONS: Goeckerman regimen is a very effective, safe and low-cost therapy. We confirmed, it modulates the immune system reactivity, ameliorates the severity of the disease and reduces the levels of alarmins reflecting the presence and intensity of inflammation.
650    _2
$a alarminy $7 D000067531
650    _2
$a biologické markery $7 D015415
650    _2
$a dítě $7 D002648
650    12
$a dehet uhelný $x terapeutické užití $7 D003033
650    _2
$a lidé $7 D006801
650    12
$a psoriáza $x farmakoterapie $7 D011565
650    _2
$a stupeň závažnosti nemoci $7 D012720
655    _2
$a časopisecké články $7 D016428
700    1_
$a Císařová, Barbora $u Institute of Preventive Medicine, Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic $7 xx0273648
700    1_
$a Borský, Pavel, $u Institute of Pathological Physiology, Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic. borskyp@lfhk.cuni.cz $u Institute of Preventive Medicine, Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic. borskyp@lfhk.cuni.cz $d 1992- $7 xx0268728
700    1_
$a Fiala, Zdeněk, $u Institute of Preventive Medicine, Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic $d 1955- $7 nlk19990073147
700    1_
$a Andrýs, Ctirad, $u Institute of Clinical Immunology and Allergology, University Hospital and Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic $d 1962- $7 mzk2008430528
700    1_
$a Hamáková, Květoslava $u Clinic of Dermal and Venereal Diseases, University Hospital, Hradec Králové, Czech Republic $7 xx0064204
700    1_
$a Švadláková, Tereza $u Institute of Clinical Immunology and Allergology, University Hospital and Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic $u Institute of Preventive Medicine, Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic $7 xx0268729
700    1_
$a Krejsek, Jan, $u Institute of Clinical Immunology and Allergology, University Hospital and Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic $d 1958- $7 nlk19990073429
700    1_
$a Palička, Vladimír, $u Institute of Clinical Biochemistry and Diagnostics, University Hospital and Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic $d 1946- $7 jn99240000830
700    1_
$a Kotingová, Lenka, $u Institute of Preventive Medicine, Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic $d 1970- $7 xx0230083
700    1_
$a Borská, Lenka $u Institute of Preventive Medicine, Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic $7 nlk20060173900
773    0_
$w MED00010947 $t Acta Medica (Hradec Kralove) $x 1805-9694 $g Roč. 64, č. 4 (2021), s. 204-212
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35285442 $y Pubmed
910    __
$a ABA008 $b A 3077 $c 1072 $y p $z 0
990    __
$a 20220419 $b ABA008
991    __
$a 20220607092732 $b ABA008
999    __
$a ok $b bmc $g 1800782 $s 1160613
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 64 $c 4 $d 204-212 $e - $i 1805-9694 $m Acta Medica $n Acta Med. (Hradec Král.) $x MED00010947
GRA    __
$a Q40-09 $p Univerzita Karlova v Praze
GRA    __
$a Q40-10 $p Univerzita Karlova v Praze
GRA    __
$a Q40-11 $p Univerzita Karlova v Praze
GRA    __
$a SVV-260543/2020 $p Univerzita Karlova v Praze
LZP    __
$b NLK138 $a Pubmed-20220419

Najít záznam

Citační ukazatele

Možnosti archivace